UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000018654
Receipt number R000021592
Scientific Title Randomized comparative trial of vonoprazan and esomeprazole in triple therapy for the eradication of Helicobacter pylori.
Date of disclosure of the study information 2015/08/14
Last modified on 2021/10/15 10:59:45

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Randomized comparative trial of vonoprazan and esomeprazole in triple therapy for the eradication of Helicobacter pylori.

Acronym

Comparative trial of vonoprazan and esomeprazole for the eradication of Helicobacter pylori (VEHP trial)

Scientific Title

Randomized comparative trial of vonoprazan and esomeprazole in triple therapy for the eradication of Helicobacter pylori.

Scientific Title:Acronym

Comparative trial of vonoprazan and esomeprazole for the eradication of Helicobacter pylori (VEHP trial)

Region

Japan


Condition

Condition

Chronic gastritis with Helicobacter pylori infection

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy and safety of vonoprazan based triple therapy compared with esomeprazole based therapy as first-line eradication therapy for patients with Helicobacter pylori infection.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Explanatory

Developmental phase

Phase IV


Assessment

Primary outcomes

Eradication rate of the first-line therapy assessed by a urea breath test from 6 to 10 weeks after cessation of therapy.

Key secondary outcomes

Eradication rate of second-line therapy with vonoprazan in the patients who failed first-line therapy.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification

YES

Dynamic allocation

NO

Institution consideration

Institution is considered as a block.

Blocking


Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Vonoprazan 40mg, ABPC 1500mg, CAM 400mg, for the first 7days, with all drugs given twice daily

Interventions/Control_2

Esomeprazole 40mg, ABPC 1500mg, CAM 400mg, for the first 7 days, with all drugs given twice daily

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who received a diagnosis of Helicobacter pylori gastritis by any one method of a rapid urease test, a urea breath test, a blood antibody test, a stool antigen test, and microbial culture.

Key exclusion criteria

1. Patients who suggested or received a diagnosis of other infectious diseases.
2. Patients who received a diagnosis of acute gastritis, advanced gastric cancer, gastric MALT lymphoma, and postgastrectomy by endoscopic examination.
3. Patients who have coexisting severe heart disease, liver disease, renal disease, respiratory disease, metabolic disease, and neuromuscular disease.
4. Patients who received any one of lansoprazole, esomeprazole, omeprazole, and vonoprazan within 2 weeks.
5. Patients who have histories of eradication therapy for Helicobacter pylori.
6. Patients who have a past history of allergy for vonoprazan, esomeprazole, amoxicillin, clarithromycin, and metronidazor.
7. Pregnancy.

Target sample size

520


Research contact person

Name of lead principal investigator

1st name Hiroyuki
Middle name
Last name Tamaki

Organization

Takamatsu Redcross Hospital

Division name

Gastroenterology

Zip code

7600075

Address

4-1-3, Ban-cho, Takamatsu , Kagawa

TEL

087-831-7101

Email

h-tama@gc4.so-net.ne.jp


Public contact

Name of contact person

1st name Hiroyuki
Middle name
Last name Tamaki

Organization

Takamatsu Redcross Hospital

Division name

Gastroenterology

Zip code

7600075

Address

4-1-3, Ban-cho, Takamatsu , Kagawa

TEL

087-831-7101

Homepage URL


Email

h-tama@gc4.so-net.ne.jp


Sponsor or person

Institute

Takamatsu Redcross Hospital

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Takamatsu Red Cross Hospital

Address

4-1-3, Ban-cho, Takamatsu, Kagawa, Japan

Tel

0878317101

Email

tamaki33@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

高松赤十字病院(香川)、石川クリニック(香川)、関西電力病院(大阪)、なお消化器クリニック(静岡)、天理よろづ相談所病院(奈良)、よしなれクリニック(香川)、なかじまクリニック(兵庫)、京都桂病院(京都)


Other administrative information

Date of disclosure of the study information

2015 Year 08 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2015 Year 06 Month 08 Day

Date of IRB


Anticipated trial start date

2015 Year 06 Month 08 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 08 Month 12 Day

Last modified on

2021 Year 10 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000021592


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name